Company Filing History:
Years Active: 2021
Title: Michael Crapanzano: Innovator in Peptoid Affinity Ligands
Introduction
Michael Crapanzano is a notable inventor based in Baton Rouge, LA (US). He has made significant contributions to the field of biochemistry, particularly in the development of peptoid affinity ligands. With a total of 2 patents, his work focuses on innovative methods for binding and purifying immunoglobulins and related compounds.
Latest Patents
Crapanzano's latest patents include advancements in peptoid affinity ligands. These patents disclose peptoids and related compounds designed for binding and purifying immunoglobulins, immunoglobulin fragments, or immunoglobulin fusion proteins. The methods outlined in these patents detail the creation of peptoid affinity ligands that consist of sequentially coupled peptoid residues forming a peptoid backbone. Functional groups are appended to the nitrogen of the peptoid residues to achieve the desired binding affinity. Additionally, hybrid peptoids are introduced, which feature a peptoid backbone with functional groups coupled to an alpha carbon of a peptide bond, enhancing their utility in various applications.
Career Highlights
Crapanzano is associated with Mike-ann, LLC, where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in medical and research settings, particularly in the purification of immunoglobulins.
Collaborations
Some of his notable coworkers include Andrew J Murphy and Tee Bordelon, who contribute to the collaborative efforts in advancing the research and development of peptoid affinity ligands.
Conclusion
Michael Crapanzano's contributions to the field of biochemistry through his patents on peptoid affinity ligands highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to pave the way for new methodologies in the purification of immunoglobulins and related compounds.